The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Slaughter and May

Living Wage
ONE BUNHILL ROW, LONDON, EC1Y 8YY, ENGLAND
Tel:
Work 020 7600 1200
Fax:
Fax 020 7090 5000
DX:
11 LONDON CHANCERY LANE WC2
Email:
Web:
www.slaughterandmay.com
Beijing, Brussels, Hong Kong, London

Susie Middlemiss

Tel:
Work 020 7600 1200
Email:
Slaughter and May

Work Department

Intellectual Property.

Position

Partner. Susie is Head of the firm's Intellectual Property practice and Co-Head of the Pharmaceuticals, Biotechnology and Healthcare practice. Susie has extensive experience in a wide range of intellectual property matters dealing with all forms of intellectual property rights. Her litigation practice includes experience in the High Court, the IPEC and the European Patent Office, and advising in multi-jurisdictional disputes, particularly concerning patents and trade marks. Her experience covers a range of sectors and technology. In addition, Susie is involved in mediation and other forms of dispute resolution.

Career

Qualified New South Wales 1986; England and Wales 1991; Slaughter and May 1995; partner 2000.

Member

INTA (2007 Volunteer Service Award); CIPA (associate member); BIA IP advisory committee; editorial committee of ‘Bioscience Law Review’.

Education

University of Sydney (BSc; LLB).


London: TMT (technology, media and telecoms)

Intellectual property

Within: Intellectual property

The 'technically strong' intellectual property team at Slaughter and May provides 'well-thought-out advice' particularly in strategic, commercial and transactional matters. The group is instructed by Tata Steel Group on complex IP element of the company's €15bn joint venture with thyssenkrupp, this included brand licensing and research and development agreements. In another work highlight, the department acted for Tottenham Hotspur  on its kit supply and sponsorship agreement with Nike.  Susie Middlemiss heads the practice and has particular expertise in disputes, while Cathy Connolly leads on non-contentious IP matters. Other key names to note include David Ives, particularly for international licensing arrangements, and recently promoted partner Duncan Blaikie.

[back to top]

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

Corporate, commercial, transactions and IP are the core areas of focus for Slaughter and May. Susie Middlemiss co-heads the team and has expertise in disputes and IP work. Fellow practice head David Johnson focuses on corporate and commercial transactions and assisted GlaxoSmithKline with the $619m sale of its 6.2% stake in Aspen Pharmacare. Alongside Johnson, corporate transactions expert Simon Nicholls worked with Actelion on its sale to Johnson & Johnson. Corporate and commercial law specialist Richard Smith advised Immunocore on its collaboration with the Bill & Melinda Gates Foundation, which will focus on developing treatments for HIV and TB using T-cell receptors.

[back to top]


Back to index

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to